Cronos Group (CRON) Competitors

Cronos Group (NASDAQ:CRON) and Alvotech (NASDAQ:ALVO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking.

Do analysts rate CRON or ALVO?

Cronos Group currently has a consensus price target of $3.50, suggesting a potential upside of 103.49%. Alvotech has a consensus price target of $18.00, suggesting a potential upside of 111.02%. Given Alvotech's stronger consensus rating and higher probable upside, analysts plainly believe Alvotech is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Alvotech	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor CRON or ALVO?

In the previous week, Alvotech had 5 more articles in the media than Cronos Group. MarketBeat recorded 8 mentions for Alvotech and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.75 beat Alvotech's score of 0.18 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Alvotech	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher earnings & valuation, CRON or ALVO?

Cronos Group has higher earnings, but lower revenue than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$117.62M	5.64	-$73.96M	$0.10	17.20
Alvotech	$489.68M	5.25	-$551.73M	-$0.87	-9.80

Is CRON or ALVO more profitable?

Cronos Group has a net margin of -42.65% compared to Alvotech's net margin of -123.47%. Alvotech's return on equity of 0.00% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-2.56%	-2.47%
Alvotech	-123.47%	N/A	-35.87%

Do institutionals & insiders have more ownership in CRON or ALVO?

8.7% of Cronos Group shares are held by institutional investors. 6.9% of Cronos Group shares are held by company insiders. Comparatively, 0.5% of Alvotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more volatility and risk, CRON or ALVO?

Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Alvotech has a beta of -0.05, suggesting that its stock price is 105% less volatile than the S&P 500.

Does the MarketBeat Community believe in CRON or ALVO?

Cronos Group received 457 more outperform votes than Alvotech when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 50.00% of users gave Alvotech an outperform vote.

Company	Underperform	Outperform
Cronos Group	Outperform Votes 464 61.13%	Underperform Votes 295 38.87%
Alvotech	Outperform Votes 7 50.00%	Underperform Votes 7 50.00%

Summary

Cronos Group beats Alvotech on 11 of the 18 factors compared between the two stocks.